Find Buphenine hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 849-55-8, Buphenine hydrochloride, Nylidrin (hydrochloride), Nylidrin hcl, Arlibide, Arlidin
Molecular Formula
C19H26ClNO2
Molecular Weight
335.9  g/mol
InChI Key
CLJHABUMMDMAFA-UHFFFAOYSA-N
FDA UNII
EC69E3PW7E

Buphenine hydrochloride
A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
1 2D Structure

Buphenine hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride
2.1.2 InChI
InChI=1S/C19H25NO2.ClH/c1-14(8-9-16-6-4-3-5-7-16)20-15(2)19(22)17-10-12-18(21)13-11-17;/h3-7,10-15,19-22H,8-9H2,1-2H3;1H
2.1.3 InChI Key
CLJHABUMMDMAFA-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(CCC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
EC69E3PW7E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Arlidin

2. Bufenine

3. Buphenin

4. Buphenine

5. Dilatol

6. Hydrochloride, Nylidrin

7. Nylidrin

2.3.2 Depositor-Supplied Synonyms

1. 849-55-8

2. Buphenine Hydrochloride

3. Nylidrin (hydrochloride)

4. Nylidrin Hcl

5. Arlibide

6. Arlidin

7. Buphedrin

8. Dilatol

9. Vasiten

10. Buphenin Hydrochloride

11. Nsc-142004

12. Mls000069387

13. Dilatyl

14. Suprifen Psb Hydrochloride

15. 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride

16. Smr000058488

17. Nylidrin Hydrochloride (jan)

18. Ec69e3pw7e

19. Nylidrin Hydrochloride [jan]

20. Sr-01000002981

21. Buphenine Hcl

22. P-hydroxy-.alpha.-[1-[(1-methyl-3-phenylpropyl)amino]ethyl]benzyl Alcohol Hydrochloride

23. P-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)benzyl Alcohol Hydrochloride

24. Arlidin (tn)

25. Nylidrine Hydrochloride

26. Opera_id_1722

27. Mls001076116

28. Schembl364078

29. Spectrum1500445

30. Chembl1204337

31. Chebi:31925

32. Dtxsid20957360

33. Hms1920d06

34. Pharmakon1600-01500445

35. Nylidrin Hydrochloride [mi]

36. Amy23363

37. Hy-b1404

38. Tox21_500911

39. Ccg-40183

40. Mfcd00035085

41. Nsc142004

42. Nsc757252

43. S5267

44. Nylidrin Hydrochloride [vandf]

45. Wln: Qr Dyqy1&my1&2r &gh

46. Akos030242878

47. Buphenine Hydrochloride [mart.]

48. Cs-4980

49. Lp00911

50. Nsc-757252

51. Buphenine Hydrochloride [who-dd]

52. Ncgc00094222-01

53. Ncgc00094222-02

54. Ncgc00094222-03

55. Ncgc00094222-04

56. Ncgc00261596-01

57. As-19644

58. Eu-0100911

59. Ft-0757340

60. N-153

61. D01543

62. A923155

63. Q9668243

64. Sr-01000002981-2

65. 4-(1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl)phenol Hydrochloride

66. 1-p-hydroxyphenyl-2-[(1'-methyl-3'-phenylpropyl)amino]-1-propanol Hydrochloride

67. 4-{1-hydroxy-2-[(4-phenyl-2-butanyl)amino]propyl}phenol Hydrochloride (1:1)

68. 900-01-6

69. Benzenemethanol, 4-hydroxy-.alpha.-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-, Hydrochloride

2.4 Create Date
2006-03-07
3 Chemical and Physical Properties
Molecular Weight 335.9 g/mol
Molecular Formula C19H26ClNO2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count3
Rotatable Bond Count7
Exact Mass335.1652068 g/mol
Monoisotopic Mass335.1652068 g/mol
Topological Polar Surface Area52.5 Ų
Heavy Atom Count23
Formal Charge0
Complexity296
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count3
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Sympathomimetics

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Adrenergic beta-Agonists

Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)


Tocolytic Agents

Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty